• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Done Global Executives Sentenced to Prison in $90M Online Adderall Fraud Case

by Jasmine Pennic 07/07/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know

  • Ruthia He, the founder and former CEO of digital mental health startup Done Global Inc., has been sentenced to six years in prison and a fine of $1M for orchestrating a massive telehealth prescription fraud scheme.
  • Co-defendant David Brody, Done’s former clinical president, was separately sentenced to two years in prison and fined $1M after admitting he personally authorized over 394,000 Schedule II stimulant pills for patients he never evaluated.
  • Driven by a subscription-for-prescription business model aimed at a $1 billion valuation, the company unlawfully distributed over 37 million pills of Adderall and defrauded commercial and federal insurers of more than $12M.
  • Done Global bypassed medical necessity by enforcing short-visit protocols, penalizing cautious clinicians, and employing an automated “auto-refill” platform feature that pushed stimulant renewals with zero clinical oversight.
  • The landmark prosecution stands as the first sentencing under the Justice Department’s newly established West Coast Strike Force, sending an unmistakable warning to digital health box suites regarding controlled substance governance.

Deconstructing the Fraudulent Architecture: The Auto-Refill Loop

The court documents expose a calculated ecosystem where technology, clinical protocols, and management incentive structures were woven together to bypass medical necessity. Seeking an over $1 billion valuation to attract institutional capital, Done Global executed a subscription-for-prescription architecture. Patients paid a flat monthly fee to secure easy access to Schedule II stimulants, driven by over $40 million in deceptive social media advertisements that engineered a massive wave of self-diagnosed attention deficit hyperactivity disorder (ADHD).

Once users entered the digital funnel, Done Global implemented automated mechanisms to strip clinicians of their professional discretion:

  • Enforced Visit Compression: Initial clinical evaluations were explicitly capped at half the length of a standard psychiatric examination, forcing high-speed, uncalibrated diagnoses.
  • The “Santa Claus” Compensation Model: Clinicians who bucked the trend were terminated or locked out, while prescribers who signed off on Adderall scripts every 30 seconds were rewarded with compensation packages reaching up to $60,000 per month.
  • The Auto-Refill Mechanism: After an introductory encounter, the platform initiated an automated refill feature. Providers authorized subsequent stimulant orders based on a background system message indicating a patient desired a refill, requiring no follow-up evaluation.
  • Total Disconnection from the Patient: Under these policies, some members went years without human clinical contact, with the system pushing automatic refills even through involuntary psychiatric holds or after the patients had died.

The depth of this medical abdication was personified by clinical president David Brody himself, who personally authorized 394,324 stimulant pills for 6,559 Done members—complete strangers whose medical records he admitted he never checked, spending a mere 30 seconds per refill.


Evading the Blocks: Shell Companies and Disappearing Messages

The federal investigation reveals that Done Global’s leadership operated with complete awareness of their legal liability. Clinical leaders repeatedly warned Ruthia He that the company faced severe legal exposure for promoting unlawful prescribing patterns. Rather than recalibrating the clinical logic, He responded to employees by joking that she would purchase a luxury car for the first person to be arrested.

When prominent national pharmacy chains began blocking Done prescriptions due to severe clinical safety concerns, the executives did not implement a compliance audit. Instead, internal records show that He created a secondary shell entity, Mindful Mental Wellness, for the explicit purpose of bypassing pharmacy blocks and keeping the pills flowing.

Furthermore, to ensure members could use insurance to fund their monthly fees, the co-conspirators submitted fraudulent prior authorization requests to Medicare, Medicaid, and commercial carriers—falsely claiming the platform utilized objective urine drug screens and followed DSM-5 criteria, stealing over $12.3 million in taxpayer and commercial healthcare funds.

As federal agencies closed in, the founder executed an aggressive campaign to obstruct justice. Upon receiving a federal grand jury subpoena, He ordered employees to migrate off company servers onto encrypted networks like Signal and WhatsApp, turning on disappearing message protocols to permanently destroy corporate artifacts.

Agents ultimately intercepted He at the airport in February 2023 as she attempted to flee to Hong Kong. She later secretly obtained alternative international travel documents and established an overseas shell entity, MakeBelieve Asia, to transfer millions of dollars outside the jurisdiction of United States law enforcement.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |